CHMA
Price:
$3.76
Market Cap:
$0
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2015-07-16
Stock Exchange
NASDAQ
Ticker
CHMA
According to Chiasma, Inc.’s latest financial reports and current stock price. The company's current ROE is -84.23%. This represents a change of 163.87% compared to the average of -31.92% of the last 4 quarters.
The mean historical ROE of Chiasma, Inc. over the last ten years is -51.53%. The current -84.23% ROE has changed 63.47% with respect to the historical average. Over the past ten years (40 quarters), CHMA's ROE was at its highest in in the June 2015 quarter at 9.49%. The ROE was at its lowest in in the March 2021 quarter at -48.73%.
Average
-51.53%
Median
-47.08%
Minimum
-91.61%
Maximum
-6.19%
Discovering the peaks and valleys of Chiasma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 306.03%
Maximum Annual ROE = -6.19%
Minimum Annual Increase = -87.91%
Minimum Annual ROE = -91.61%
Year | ROE | Change |
---|---|---|
2020 | -81.47% | 92.39% |
2019 | -42.35% | -53.78% |
2018 | -91.61% | 113.35% |
2017 | -42.94% | -39.77% |
2016 | -71.29% | 183.53% |
2015 | -25.14% | 306.03% |
2014 | -6.19% | -87.91% |
The current ROE of Chiasma, Inc. (CHMA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-71.81%
5-year avg
-65.93%
10-year avg
-51.53%
Chiasma, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chiasma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chiasma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Chiasma, Inc.'s ROE?
How is the ROE calculated for Chiasma, Inc. (CHMA)?
What is the highest ROE for Chiasma, Inc. (CHMA)?
What is the 3-year average ROE for Chiasma, Inc. (CHMA)?
What is the 5-year average ROE for Chiasma, Inc. (CHMA)?
How does the current ROE for Chiasma, Inc. (CHMA) compare to its historical average?